Epstein Secrets

. Bloomberg <https://www.bloomberg.com/news/articles/2020-09-22/pfizer-s-covid-vaccine-trial-plan-may-beat- rivals-to-early-look?smd=premium> (9/22, Langreth, 4.73M) reports, "The Covid-19 vaccine trial designed by Pfizer Inc. and its German partner BioNTech SE may allow them to find whether their shot wo

rosecutors were straining to make their case." The New York Post <https://nypost.corn/2020/09/22/china-denies-it-had-a-spy-inside-the-nypdk (9/22, Fonrouge, 4.57M) reports that Wang Wenbin told reporters, "The relevant accusations made by the US side are pure fabrication," adding that "the US plot to di

Biden and Kamala Harris undermining the confidence of the American people." Pfizer's COVID Vaccine Trial On Track To Beat Rivals. Bloomberg (9/22, Langreth, 4.73M) reports, "The Covid-19 vaccine trial designed by Pfizer Inc. and its German partner BioNTech SE may allow them to find whether their shot wo

f hedging terms such as `seems' and 'possibly,' giving the appearance that prosecutors were straining to make their case." The New York Post (9/22, Fonrouge, 4.57M) reports that Wang Wenbin told reporters, "The relevant accusations made by the US side are pure fabrication," adding that "the US plot to d

lity of protection is. We're following it very closely." Modern Joins Pfizer In Exporting US-Manufactured Vaccine Doses. Bloomberg (5/20, Wingrove, Langreth, 3.57M) reports that Moderna "has begun exporting U.S.-produced Covid-19 vaccines to other countries, a key step as U.S. vaccine supply begins to be

deaths in New York State nursing homes." The Wall Street Journal (5/20, Mullin, Vielkind, Subscription Publication, 8.41M), the New York Post (5/20, Fonrouge, 7.45M), and the New York Daily News (5/20, Shahrigian, 2.51M) also report. WPost: Postal Reform Measure Is Good, But Insufficient. A Washington P

Biden and Kamala Harris undermining the confidence of the American people." Pfizer's COVID Vaccine Trial On Track To Beat Rivals. Bloomberg (9/22, Langreth, 4.73M) reports, "The Covid-19 vaccine trial designed by Pfizer Inc. and its German partner BioNTech SE may allow them to find whether their shot wo

f hedging terms such as 'seems' and 'possibly,' giving the appearance that prosecutors were straining to make their case." The New York Post (9/22, Fonrouge, 4.57M) reports that Wang Wenbin told reporters, "The relevant accusations made by the US side are pure fabrication," adding that "the US plot to d